Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma

BJU International

Volumn 106, Issue 5, 2010, Pages 658-663

  Lodde, Michele ^a   Lacombe, Louis ^a   Friede, Juan ^b   Morin, Francis ^b   Saourine, Alexandre ^a   Fradet, Yves ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

CT; metastasis; PET; staging; urothelial cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; METHYLENE DIPHOSPHONIACIDE TECHNETIUM 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SCINTISCANNING; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIURESIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LUNG BIOPSY; LUNG CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM METASTASIS; PATIENT MONITORING; PELVIS LYMPH NODE; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; UROTHELIAL BLADDER CARCINOMA;

AGED; AGED, 80 AND OVER; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77955903671     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09212.x     Document Type: Article

References (25)

1. Herr HW, Faulkner JR, Grossman HB et al.Surgical factors influence bladder cancer outcomes: a cooperative group report. vJ Clin Oncol 2004; 22 : 27819
2. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349 : 85966
3. Calabro F, Sternberg CN. Neoadjuvant and adjuvant chemotherapy in muscleinvasive bladder cancer. Eur Urol 2009; 55 : 34858
4. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238 : 40522
5. Koyama K, Okamura T, Kawabe J et al. Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. J Nucl Med 2003; 44: 3538
6. Picchio M, Treiber U, Beer AJ et al. Value of 11C-choline PET and contrastenhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 2006; 47: 93844
7. Gofrit ON, Mishani E, Orevi M et al. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol 2006; 176: 9404
8. Kosuda S, Kison PV, Greenough R et al. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 1997; 24: 615 20
9. Drieskens O, Oyen R, Van Poppel H et al. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005; 32: 14127
10. Hoekstra CJ, Paglianiti I, Hoekstra OS et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-dglucose and positron emissiontomography: an overview of different analytical methods. Eur J Nucl Med 2000; 27: 73143
11. Beck JR. Likelihood ratios. Another enhancement of sensitivity and specificity. Arch Pathol Lab Med 1986; 110 : 6856
12. Powles T, Murray I, Brock C et al. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007; 51: 151120
13. Hoh CK, Schiepers C, Seltzer MA et al. PET in oncology: will it replace the other modalities? Semin Nucl Med 1997; 27: 94106
14. Holder WD Jr, White RL Jr, Zuger JH et al. Effectiveness of positron emission tomography for the detection of melanoma metastases. Ann Surg 1998; 227: 7649
15. Ogunbiyi OA, Flanagan FL, Dehdashti F et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997; 4: 61320
16. Graeber GM, Gupta NC, Murray GF. Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease. J Thorac Cardiovasc Surg 1999; 117: 71927
17. Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 1998; 16: 1099102
18. Sanderson KM, Cai J, Miranda G et al. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J Urol 2007; 177: 208894
19. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 66675
20. Fleischmann A, Thalmann GN, Markwalder R et al. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005; 23: 235865 (Pubitemid 46218729)
21. Honma I, Masumori N, Sato E et al. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer analysis of role of pelvic lymph node dissection. Urology 2006; 68: 5438
22. Vazina A, Dugi D, Shariat SF et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004; 171: 18304
23. Abol-Enein H, El-Baz M, Abd El-Hameed MA et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study a single center experience. J Urol 2004; 172: 181821
24. Min JW, Um SW, Yim JJ et al. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. J Korean Med Sci 2009; 24: 27580
25. Cheran SK, Herndon JE II, Patz EF Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004; 44: 31725